What if the tumor you’re treating is already yesterday’s news? In this riveting episode of Metabolic Matters, Dr. Nasha Winters sits down with Dr. John A. Catanzaro, NMD, PhD—Co-Founder and CEO of Neo7Bioscience and one of the leading innovators in personalized peptide therapeutics and molecular surveillance. With over 25 years at the intersection of clinical medicine, molecular biology, and translational research, Dr. Catanzaro specializes in understanding the real-time biology driving cancer, autoimmunity, chronic inflammation, degenerative disease, and mRNA-related injuries. His proprietary PBIMA® and REViSS® platforms analyze genomics, transcriptomics, proteomics, and AHI-driven analytics to design patient-specific peptide sequences tailored to each individual’s molecular signature.

Connect with Dr. John:

About Your Host

I’m Dr. Nasha Winters, a global healthcare authority, best-selling author, and educator in the emerging field of integrative oncology and terrain-based cancer care. I host Metabolic Matters to explore the intersections between metabolism, medicine, and meaning.

Subscribe, Share & Review

If you loved this conversation, please subscribe, rate, and share with a friend or clinician who needs to hear it.

Support & Resources:

Support Patient Grants: www.mtih.org
Book: The Metabolic Approach to Cancer
Education Programs: www.metabolicregen.com
Supplements: mitovida.com

Follow on Socials

Hosted on Acast. See acast.com/privacy for more information.

Initial College Football Playoff Rankings Release LIVE: Instant Reaction

The Buckeye Weekly Podcast

Bubble teams and Notre Dame’s path

The AI-powered Podcast Player